Pfizer's Viagra to faces stiff competition

Published: 2011-09-14 06:59:00

Updated: 2011-09-14 06:59:00

Pfizer, which so far has been leading the domestic erectile dysfunction drugs market with its flagship medicine Viagra, will face a fiercer competition as the patent on Viagra expires in May 17 of 2012.

Currently, 20-odd Korean companies who see opportunities in the field are expected to relea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK